Exercise of SAYE Options, Director Dealing & TVR

Craneware plc

("Craneware" or the "Company")

Exercise of SAYE Options, Director Dealing

and Total Voting Rights

1 November 2023 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated Value Cycle solutions for the US healthcare market, announces that on 31 October 2023, options over ordinary shares of 1p each in the Company ("Ordinary Shares") were exercised under the terms of the Craneware plc SAYE Option Plan (2018) by certain employees and Directors (the "SAYE Options" and together, the "Exercise").

Included within the Exercise was an aggregate of 3,136 SAYE Options exercised by the following Directors:

Following this transaction, Keith Neilson holds 3,467,707 Ordinary Shares, representing 9.81% of the total voting rights of the Company and Craig Preston holds 100,417 Ordinary Shares representing 0.28% of the total voting rights of the Company, as described below.

Total Voting Rights

Following the Exercise and also the earlier exercise of SAYE Options and receipt of employee vested share plan awards by certain other employees in the period since 16 October 2023, the Company is transferring or has transferred a total of 13,380 Ordinary Shares previously held in treasury to satisfy the transactions. As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 179,082 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,363,087. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

PDMR notification: Keith Neilson

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                             Keith Neilson

2.   Reason for the notification

a) Position / status                                             CEO

b) Initial notification / Amendment                       Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                              Craneware plc

b) LEI                                                                 213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument                                                      Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code                                           ISIN GB00B2425G68

c) Nature of the transaction                                    Exercise of options over Ordinary Shares

d) Price(s) and volume(s)                                      Volume(s) 1,568 , Price(s) £11.475

e) Aggregated information:                                  N/A (single transaction)

                                    i. Aggregated volume             -

                                    ii. Price(s)                              -

f) Date of the transaction                                     2023-10-31

       g) Place of the transaction                                   Outside a trading venue

PDMR notification: Craig Preston

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                     Craig Preston

2.   Reason for the notification

a) Position / status                                     CFO

b) Initial notification / Amendment               Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                     Craneware plc

b) LEI                                                        213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument                                                  Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code                                  ISIN GB00B2425G68

c) Nature of the transaction                         Exercise of options over Ordinary Shares

d) Price(s) and volume(s)                            Volume(s) 1,568, Price(s) £11.475

e) Aggregated information:                         N/A (single transaction)

                                    i. Aggregated volume     -

                                    ii. Price(s)                     -

f) Date of the transaction                           2023-10-31

g) Place of the transaction                          Outside a trading venue

For further information, please contact:

Craneware plc                                                                                      +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

Alma (Financial PR)                                                                             +44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon                                       [email protected]

Peel Hunt (NOMAD and Joint Broker)                                                   +44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers, Kate Bannatyne

Investec Bank PLC (Joint Broker)                                                         +44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint Broker)                                                                      +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware  Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable  value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

Learn more at www.thecranewaregroup.com